Search for: "In re Hatch"
Results 481 - 500
of 1,015
Sort by Relevance
|
Sort by Date
10 Sep 2012, 5:46 am
Perhaps what moves him most about this office is the spirit of "mutual assistance" that can end up with Senator Orrin Hatch "waist deep in a septic tank" helping a neighbor with manual work. [read post]
10 Sep 2012, 3:57 am
(So, too, on several occasions, conservative Senators such as Orrin Hatch, Trent Lott, and John Cornyn have invited me to testify on Capitol Hill.) [read post]
7 Sep 2012, 9:42 pm
But when you’re not necessarily trying to broaden your reach to the Spanish-speaking market, things get lost in translation. [read post]
4 Sep 2012, 7:04 am
We previously reported on developments in various United States Courts of Appeal decisions concerning reverse payments in Hatch-Waxman litigation settlements - that is, payments made by branded pharmaceutical patent holders to generic challengers to postpone market entry of the generic product. [read post]
1 Sep 2012, 5:46 pm
Teens just don’t want to listen, no matter how many times they’re warned. [read post]
22 Aug 2012, 1:09 am
Rather than pass those savings along to the funds, the adviser allegedly hatched a plan to pocket the savings. [read post]
14 Aug 2012, 8:50 pm
In a “no-AG” agreement or commitment, the branded firm, as part of a patent settlement, agrees that it will not launch its own generic alternative when the first generic begins to compete.The issue addressed by the FTC in Effexor is whether a branded drug company’s commitment not to launch an authorized generic drug in competition with a generic qualifies as a “reverse payment” under last month’s Third Circuit’s ruling in In Re: K-Dur Antitrust… [read post]
14 Aug 2012, 8:50 pm
In a “no-AG” agreement or commitment, the branded firm, as part of a patent settlement, agrees that it will not launch its own generic alternative when the first generic begins to compete.The issue addressed by the FTC in Effexor is whether a branded drug company’s commitment not to launch an authorized generic drug in competition with a generic qualifies as a “reverse payment” under last month’s Third Circuit’s ruling in In Re: K-Dur Antitrust… [read post]
14 Aug 2012, 8:50 pm
In a “no-AG” agreement or commitment, the branded firm, as part of a patent settlement, agrees that it will not launch its own generic alternative when the first generic begins to compete.The issue addressed by the FTC in Effexor is whether a branded drug company’s commitment not to launch an authorized generic drug in competition with a generic qualifies as a “reverse payment” under last month’s Third Circuit’s ruling in In Re: K-Dur Antitrust… [read post]
14 Aug 2012, 1:55 pm
But this gave him time to hatch his plot to request asylum. [read post]
14 Aug 2012, 12:58 pm
In In re K-Dur Antitrust Litig., No. 10-2079 (3rd Cir. 2012), the U.S. [read post]
14 Aug 2012, 12:58 pm
In In re K-Dur Antitrust Litig., No. 10-2079 (3rd Cir. 2012), the U.S. [read post]
9 Aug 2012, 9:56 am
The plan was hatched by a private outfit, the same private investors who would be the obvious beneficiaries of the plan, if it worked. [read post]
7 Aug 2012, 7:27 am
And if you don’t, you’re going face obviousness-type double patenting problems. [read post]
6 Aug 2012, 1:01 am
Correct me if I’m wrong here, but even most multinationals aren’t nearly organized and farsighted enough to hatch a scheme like this. [read post]
2 Aug 2012, 2:31 am
August 2, 2012 When you're hired at Google, you only have to do the job you were hired for 80% of the time. [read post]
31 Jul 2012, 7:25 am
The Third Circuit opinion relies heavily on the goals of the 1984 Hatch-Waxman Act. [read post]
30 Jul 2012, 7:33 am
“Don’t count your chickens before they hatch”. [read post]
20 Jul 2012, 12:26 pm
Cir. 2001); and In re Cardizem CD Antitrust Litig., 332 F.3d 896 (6th Cir. 2003). [read post]
18 Jul 2012, 5:20 am
On Monday, in In Re: K-Dur Antitrust Litigation, No. 10-2078 (3rd Cir. [read post]
